September 2005

Beyond Clonal DetectionDefining the T-Cell Clone

Author Affiliations

Copyright 2005 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.2005

Arch Dermatol. 2005;141(9):1159-1160. doi:10.1001/archderm.141.9.1159

In this issue of the ARCHIVES, Juarez et al1 studied the prognostic value of nodal T-cell receptor gene rearrangement analysis in cutaneous T-cell lymphoma (CTCL). They found that the predictive outcome value of T-cell clonality by any method was inferior to that of a simple clinical skin assessment (T stage). They also found that clinical detection of lymphadenopathy (N1 stage) was pragmatically more relevant than finding a T-cell clone by polymerase chain reaction (PCR). Furthermore, they concluded that the old Southern blot clonality test, which has been broadly replaced by more practical and sensitive PCR-based analysis, was more effective than PCR in predicting a poor outcome. All 15 study patients with positive clonality by Southern blot died in less than 10 years.

First Page Preview View Large
First page PDF preview
First page PDF preview